Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine and oxaliplatin with radiation therapy for pancreatic cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Depression, Cytokines and Pancreatic Cancer
A clinical trial update indicates the study on depression and cytokines in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) [Phase 1, Phase 2]
Phase 1/2 trial evaluating low dose upper abdominal radiation therapy with gemcitabine in advanced, unresectable pancreatic cancer; study co…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating the combination of erlotinib, gemcitabine, and oxaliplatin for advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on a veliparib, oxaliplatin, and capecitabine combination in patients with advanced solid tumors. The study, including pancre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma [Phase 2]
A Phase 2, open-label, single-center trial evaluating the antibody Gastrimmune for antibody response, safety, and tolerability in advanced p…
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. [Phase 2]
A Phase 2 single-centre study assessing the antibody response to G17DT in patients with advanced pancreatic cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer [Phase 1]
Phase 1 safety update on a combination therapy (AMG 706 + panitumumab + gemcitabine-cisplatin) for advanced cancers; the trial status is ter…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy for metastatic pancreatic cancer unsuitable for surgical removal has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of combining sunitinib with gemcitabine in pancreatic cancer and other solid tu…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the gamma-secretase inhibitor RO4929097 in combination with gemcitabine in patients with advanced pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: PET-CT in Diagnosis of Pancreatic Cystic Neoplasms
A completed clinical trial evaluating PET-CT for diagnosing pancreatic cystic neoplasms.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer
This update summarizes gene expression profiling data collected from patients with metastatic pancreatic cancer in a completed clinical tria…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer [Phase 1]
Phase 1 trial of a biological therapy in surgically resected pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: AS703569 and Gemcitabine Combination in Advanced Malignancies [Phase 1]
Phase 1 trial of AS703569 in combination with gemcitabine in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer [Phase 2]
A Phase II study of TPI 287 in patients with advanced, unresectable pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer [Phase 2]
Phase 2 trial of oxaliplatin, gemcitabine, and erlotinib in advanced chemo-naïve pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers [Phase 2]
A Phase 2 study evaluating S-1 as second-line treatment for advanced pancreatic cancer is underway; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial studied the combination of docetaxel and flavopiridol in patients with refractory metastatic pancreatic cancer; the study is…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia [Phase 1, Phase 2]
A Phase 1/2 study of NC-6004 (Nanoplatin) in combination with Gemcitabine for locally advanced and metastatic pancreatic cancer has complete…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer [NA]
A terminated clinical trial comparing medical nutrition therapy to standard care in patients with lung cancer, pancreatic cancer, or stage I…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint [Phase 2]
A Phase 2 trial evaluated the combination of panitumumab and gemcitabine for pancreatic cancer, using overall survival as the primary endpoi…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors [Phase 1]
Phase 1 trial of gemcitabine, capecitabine, and vandetanib (ZD6474) in patients with advanced solid tumors has completed, including biliary …
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay [NA]
A completed clinical trial evaluating preoperative oral immunonutrition in pancreatic cancer patients undergoing elective surgery and its ef…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Dasatinib in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A phase 2 trial assessing dasatinib in metastatic pancreatic cancer has completed with results posted.